期刊文献+

脉冲式高容量血液滤过在严重脓毒症患者中的应用 被引量:4

Application of pulse high volume hemofiltration in severe sepsis patients
下载PDF
导出
摘要 目的探讨脉冲式高容量血液滤过在严重脓毒症患者中的应用价值。方法严重脓毒症患者49例,按照随机原则分为:A组25例(脉冲式高容量血液滤过组),B组24例(持续高容量血液滤过组),进行不同方法的血液滤过治疗,记录开始和72h后APACHEⅢ评分,平均动脉压(MAP),血管活性药用量,凝血功能,生化指标,炎症指标的变化。还记录每组患者的滤器平均使用时间,置换液使用总量,肝素使用总量,28d病死率等数据,进行比较分析。结果治疗72h后,A,B两组之间平均动脉压,去甲肾上腺素用量,炎症指标水平差异均没有统计学意义(P>0.05)。B组使用的置换液量比A组明显增多,滤器平均使用时间明显缩短,B组血小板下降,APTT延长,血红蛋白下降的程度与A组比较差异有统计学意义(P<0.05)。结论在严重脓毒症患者中,脉冲式高容量血液滤过,可以达到持续高容量血液滤过的效果,又可以节约液体,耗材,减少对血液,凝血系统的影响。 Objective To investigate the advantages of pulse high volume hemofiltration in severe sepsis patients. Methods A total of 49 severe sepsis patients were divided randomly into 2 groups: group A, treated with pulse high volume hemofiltration (n=25); group B, treated with continuous high volume hemofiltration (n=24). APACHE Ⅲ score, mean artery pressure (MAP), vasoactives administration, blood coagulation function, biochemistry parameters, inflammation markers were monitored before and after the treatment for 72 hours. Average dialysis time, amount of dialysate exchanged, heparin used, and mortality rate in a 28 day period were compared between the 2 groups. Results There were no statistically significant differences in MAP, norepinephrine used, and inflammation markers after the treatment for 72 hours between the 2 groups (P 〉 0.05). However, patients in group B used more amount of exchanged dialysate, and had shorter dialysis time, less blood platelet, longer APTT, and lower hemoglobin, as compared with those in patients in group A (P 〈 0.05). Conclusions Pulse high volume hemofiltration has the similar effects as continuous high volume hemofiltration in the treatment of severe sepsis patients, but with less amount of exchanged dialysate and fewer influences on blood components and blood coagulation.
出处 《中国血液净化》 2010年第1期29-31,共3页 Chinese Journal of Blood Purification
关键词 脉冲式高容量血液滤过 高容量血液滤过 血液滤过 严重脓毒症 Pulse high volume hemofiltration High volume hemofiltration Haemofiltration Severe sepsis
  • 相关文献

参考文献7

  • 1李文歌.血液净化治疗模式的选择和临床应用[J].中国血液净化,2007,6(4):217-219. 被引量:7
  • 2Ratanarat R, Brendolan A, Ronco C. Pulse high-volume haemofiltration for treatment of severe sepsis: effects on hemodynanics and survival[J]. Crit Care, 2005,9:294 -302.
  • 3Ratanarat R, Brendolan A, Ronco C. Pulse high-volume hemofiltration in critically ill patients: a new approach for patients with septic shock[J]. Semin Dial,2006,19:69 -74.
  • 4Levy MM, Fink MP, Marshall JC, et al. 2001SCCM/ESICM/ACCP/ ATS/SIS JnternatJonal Sepsis Definitions Conference[J].Crit Care Med, 2003,31:1250-1256.
  • 5Delling RP, Leve MM, Carlet JM, et al. Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008[J].Cril Care Med, 2008,36: 296-327.
  • 6毛慧娟,王笑云.脓毒症吸附炎症介质的治疗[J].中国血液净化,2008,7(2):92-95. 被引量:5
  • 7Bouman CS, Schultz MJ, Vroom MB. Hemofiltration in sepsis and systemic inflammatory response syndrome: the role of dosing and timing[J]. J grit Care, 2007, 22:1 -12.

二级参考文献36

  • 1姚国乾,韩志武.免疫吸附疗法与临床应用进展[J].内科急危重症杂志,2006,12(1):40-43. 被引量:4
  • 2宋玉果.连续性血液净化对炎性介质清除作用的meta分析[J].中国血液净化,2006,5(1):33-37. 被引量:23
  • 3Laurent G,Charra B.The results of an 8h thrice weekly haemodilysis schedule[J].Nephrol Dial Transplant,1998,13 (suppl 6):125-131.
  • 4Charra B.Is there a magic in long nocturnal dialysis?Contrib Nephrol,2005,149:100-106.
  • 5Bosch JP,Lew SQ,Barlee V,et al.Clinical use of high efficiency hemodialysis treatment:long-term assessment.Hemodial Int,2006,10(1):73-81.
  • 6Tetta C,Bellomo R,Kellum J,et al.High volume hemofiltration in critically ill patients:why,when and how? Contrib Nephrol,2004,144:362-375.
  • 7Matic G,Bosch T,Ramlow,W.Background and indication for protein A-based extracorporeal immunoadsorption.Therapeutic Apheresis,2001,5:394-403.
  • 8Bhatia M,Moochhala S.Role of inflammatory mediators in the pathophysiology of acute respiratory distress syndrome[J].J Pathol,2004,202(2):145-156.
  • 9Ronco C,Inguaggiato P,D扞ntini V,et al.The role of extracorporeal therapies in sepsis[J].J NEPHROL,2003,16(suppl.7):S34-S41.
  • 10Marshall JC.Clinical trials of mediator-directed therapy in sepsis:what have we learned[J]? Intens Care Med,2000,26 (suppl 1):S75-83.

共引文献10

同被引文献40

  • 1蔡国龙,严静,虞意华,张昭才,龚仕金,戴海文,陈建国.高容量血液滤过对老年感染性休克合并MODS患者细胞因子的影响[J].中华急诊医学杂志,2006,15(1):57-60. 被引量:19
  • 2Angus DC,Linde-Zwirble WT, Lidicker J,et al: Epidemiology of severesepsis in the United States: Analysis of incidence, outcome, andassociated costs of care[J]. Crit Care Med 2001,29:1303–1310.
  • 3Dellinger RP: Cardiovascular management of septic shock[J]. CritCare Med 2003,31:946–955.
  • 4Martin GS, Mannino DM, Eaton S, et al: The epidemiology of sepsisin the United States from 1979 through 2000[J]. N Engl J Med 2003,348:1546–1554.
  • 5Linde-Zwirble WT, Angus DC: Severe sepsis epidemiology: Sampling,selection, and society[J].Crit Care 2004, 8:222–226.
  • 6Dombrovskiy VY, Martin AA, Sunderram J, et al: Rapid increase inhospitalization and mortality rates for severe sepsis in the UnitedStates: A trend analysis from 1993 to 2003. Crit Care Med 20.
  • 7Bellomo R, Tipping P, Boyce N. Continuous veno-venoushemofiltration with dialysis removes cytokines from thecirculation of septic patients[J]. Crit Care Med 1993, 21: 522–526.
  • 8Ronco C, Bonello M, Bordoni V et al. Extracorporeal therapies innon-renal disease: treatment of sepsis and the peak concentrationhypothesis[J]. Blood Purif 2004, 22: 164–174.
  • 9Piccinni P, Dan M, Barbacini S et al. Early isovolaemichaemofiltration in oliguric patients with septic shock[J].Intensive Care Med, 2006, 32: 80–86.
  • 10Ratanarat R, Brendolan A, Ronco C. Pulse high-volumehaemofiltration for treatment of severe sepsis: effects onhemodynamics and survival[J]. Crit Care, 2005, 9:294–302.

引证文献4

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部